APA (7th ed.) Citation

N, L., PJ, H., KK, B., GM, N., N, N., CP, D., & AM, K. (2022). Should patients with non-muscle-invasive bladder cancer discontinue fibrin clot inhibitors during bacille Calmette-Guérin? BJU international, 130(4), 463. https://doi.org/10.1111/bju.15665

Chicago Style (17th ed.) Citation

N, Lobo, Hensley PJ, Bree KK, Nogueras-Gonzalez GM, Navai N, Dinney CP, and Kamat AM. "Should Patients with Non-muscle-invasive Bladder Cancer Discontinue Fibrin Clot Inhibitors During Bacille Calmette-Guérin?" BJU International 130, no. 4 (2022): 463. https://doi.org/10.1111/bju.15665.

MLA (9th ed.) Citation

N, Lobo, et al. "Should Patients with Non-muscle-invasive Bladder Cancer Discontinue Fibrin Clot Inhibitors During Bacille Calmette-Guérin?" BJU International, vol. 130, no. 4, 2022, p. 463, https://doi.org/10.1111/bju.15665.